Patent Assignment
Reel/Frame 073058/0647
Patent Security Agreement
Recorded: 2025-10-10
Pages: 8
Assignor
KARYOPHARM THERAPEUTICS INC.
Executed: 2025-10-10
Assignee
WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
500 DELAWARE AVENUE, 11TH FLOOR, WILMINGTON, DELAWARE, 19801
Covered Properties
(25)
Uses of Il-12 as a Replacement Immunotherapeutic
Application:
16/318,670 →
Publication:
US US20240181010A1
Co-Crystal Forms of Selinexor
Methods of Synthesis of Heteroaryl Derivatives of Triazolyl Acrylamides and Crystalline Forms
Nuclear Transport Modulators and Uses Thereof
Application:
18/526,900 →
Publication:
US US20240376114A1
Nuclear Transport Modulators and Uses Thereof
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Application:
19/075,233 →
Publication:
US US20260062391A1
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
Application:
19/197,345 →
Publication:
US US20260085064A1
Polymorphs of Selinexor
Application:
19/258,063 →
Publication:
US US20260152489A1
Selinexor and Analogs for Use in the Treament of Endometrial Cancer in Patients with Wild-Type TP53 Gene
Application:
19/154,281 →
A Method of Increasing Survival of a Human Subject Having Exposure to an Acute Exposure to Non-Therapeutic Whole Body Ionization by Administering a Therapeutically Effective Dose of Il-12
Patent:
8,921,315 →
Application:
12/430,016 →
Nuclear Transport Modulators And Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
CRM1 Inhibitors for Treating Epilepsy
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Nuclear Transport Modulators and Uses Thereof
Polymorphs of Selinexor
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof
Substituted Benzofuranyl and Benzoxazolyl Compounds and Uses Thereof
The Combination of XPO1 Inhibitors and Second Agents for the Treatment of Prostate Cancer
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 29, 2017
From: SANDANAYAKA, VINCENT; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 044252/0462 →
Assignment of Assignor's Interest
Mar 6, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 045120/0273 →
Assignment of Assignor's Interest
Mar 30, 2018
From: SANDANAYAKA, VINCENT P.; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 045399/0468 →
Assignment of Assignor's Interest
Mar 30, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 045399/0458 →
Assignment of Assignor's Interest
Mar 30, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 045399/0387 →
Assignment of Assignor's Interest
Mar 30, 2018
From: SANDANAYAKA, VINCENT P.; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 045399/0348 →
Assignment of Assignor's Interest
Mar 30, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 045399/0298 →
Assignment of Assignor's Interest
Mar 30, 2018
From: SANDANAYAKA, VINCENT; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 045399/0277 →
Assignment of Assignor's Interest
Mar 30, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 045399/0233 →
Assignment of Assignor's Interest
Mar 30, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 045399/0213 →
Assignment of Assignor's Interest
Jul 6, 2018
From: SANDANAYAKA, VINCENT P.; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 046283/0934 →
Assignment of Assignor's Interest
Aug 28, 2018
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 046724/0714 →
Assignment of Assignor's Interest
Aug 28, 2018
From: SANDANAYAKA, VINCENT P.; SHECHTER, SHARON; SHACHAM, SHARON; MCCAULEY, DILARA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 046724/0670 →
Security Interest
Aug 8, 2019
From: NEUMEDICINES INC.
To: NITTO AVECIA PHARMA SERVICES, INC.
Reel/Frame 050004/0751 →
Assignment of Assignor's Interest
Dec 18, 2019
From: KARYOPHARM THERAPEUTICS INC.
To: BIOGEN MA INC.
Reel/Frame 051316/0408 →
Security Interest
Jun 16, 2020
From: NEUMEDICINES INC.
To: FRIEDMAN, ELLIOT
Reel/Frame 052956/0270 →
Assignment of Assignor's Interest
Jan 14, 2021
From: BASILE, LENA
To: NEUMEDICINES INC.
Reel/Frame 054926/0774 →
Notice of Termination and Release of Patent Liens and Security Interests
Jul 28, 2021
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 057012/0881 →
Assignment of Assignor's Interest
Jun 13, 2022
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 060181/0342 →
Assignment of Assignor's Interest
Nov 7, 2022
From: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
To: MACFARLAN SMITH LIMITED
Reel/Frame 061888/0166 →
Assignment of Assignor's Interest
May 19, 2023
From: HAMILTON, CLIFTON
To: JOHNSON MATTHEY PUBLIC LIMITED
Reel/Frame 063703/0155 →
Assignment of Assignor's Interest
Dec 15, 2023
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 065879/0436 →
Assignment of Assignor's Interest
Jun 20, 2024
From: BIOGEN MA INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 067779/0216 →
Assignment of Assignor's Interest
Sep 13, 2024
From: MACFARLAN SMITH LTD. D/B/A VERANOVA
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 068577/0890 →
Assignment of Assignor's Interest
Oct 8, 2025
From: BALOGLU, ERKAN; SHACHAM, SHARON; MCCAULEY, DILARA; KASHYAP, TRINAYAN
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 073030/0444 →